Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 08/14 03:37:15 pm
328.67 USD   +0.42%
08/03CASHING IN ON D : race on to unlock value in genetic data
RE
07/31ILLUMINA : hikes on Q2 beat
AQ
07/30ILLUMINA : 2Q Earnings Snapshot
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summaryMarketScreener Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 253.91 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 63.19 and 58.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
ILLUMINA49.80%48 547
DANAHER CORPORATION8.09%70 206
THERMO FISHER SCIENTIFIC21.88%62 233
INTUITIVE SURGICAL42.59%59 265
BOSTON SCIENTIFIC CORPORATI..35.34%46 397
ROYAL PHILIPS19.66%40 475
EDWARDS LIFESCIENCES CORPOR..22.49%28 908
CERNER CORPORATION-4.61%21 445
AGILENT TECHNOLOGIES-1.06%21 200
ABIOMED, INC.96.36%16 956
RESMED27.26%15 384
WATERS CORPORATION-1.66%14 884
OLYMPUS CORP-1.14%13 416
HOLOGIC-8.73%11 065
VARIAN MEDICAL SYSTEMS0.03%10 173
PERKINELMER16.14%9 404
More Results
Financials ($)
Sales 2018 3 310 M
EBIT 2018 916 M
Net income 2018 753 M
Finance 2018 1 461 M
Yield 2018 -
P/E ratio 2018 63,19
P/E ratio 2019 58,39
EV / Sales 2018 14,2x
EV / Sales 2019 12,4x
Capitalization 48 547 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ILLUMINA
Duration : Period : Day
Illumina Technical Analysis Chart | MarketScreener
Duration : Period : Week
Illumina Technical Analysis Chart | MarketScreener